Zydus Lifesciences Ltd.
BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
936.35
0.00
(0.00%)
< Home
< Back
Zydus Lifesciences Ltd. News
>>
Cadila Healthcare surges on reporting 52% rise in Q3 consolidated net profit
>>
Cadila Healthcare reports 52% rise in Q3 consolidated net profit
>>
Cadila Healthcare advances despite recalling cough treatment drug in US
>>
Cadila Healthcare recalls cough treatment drug in US
>>
Cadila Healthcare gains on plan to develop vaccines for ‘Congo Virus’ and ‘Ebola Virus’
>>
Cadila Healthcare edges up on plans of developing vaccines for ‘Congo Virus’ and ‘Ebola Virus’
>>
Cadila Healthcare to develop vaccines for ‘Congo Virus’ and ‘Ebola Virus’
>>
Cadila Healthcare rises on launching world’s first bio-similar of Adalimumab
>>
Zydus Cadila launches world’s first bio-similar of Adalimumab
>>
Cadila Healthcare informs about resignation of Director
<<
<
156
157
158
...168
>
>>